UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:October 22,
Arbutus Biopharma (NASDAQ:ABUS)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Arbutus Biopharma Charts.
Arbutus Biopharma (NASDAQ:ABUS)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Arbutus Biopharma Charts.

Arbutus Biopharma Corp News

Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
Thursday 2 May 2024 (4 days ago) • GlobeNewswire Inc.
Arbutus Announces Retirement of Chief Scientific Officer, Michael J. Sofia, PhD, Effective December 31, 2024
Thursday 2 May 2024 (4 days ago) • GlobeNewswire Inc.
Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update
Thursday 18 April 2024 (3 weeks ago) • GlobeNewswire Inc.
Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Against Moderna
Thursday 4 April 2024 (1 month ago) • GlobeNewswire Inc.
Arbutus to Participate in Two Upcoming Investor Conferences
Friday 8 March 2024 (2 months ago) • GlobeNewswire Inc.
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Thursday 29 February 2024 (2 months ago) • Edgar (US Regulatory)
Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update
Thursday 29 February 2024 (2 months ago) • GlobeNewswire Inc.
Arbutus to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update
Thursday 15 February 2024 (3 months ago) • GlobeNewswire Inc.
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Thursday 15 February 2024 (3 months ago) • Edgar (US Regulatory)
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Thursday 15 February 2024 (3 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 6 February 2024 (3 months ago) • Edgar (US Regulatory)

More Arbutus Biopharma Corp News Articles